Aseptic Filling Operations To Keep In-House Or Outsource

Pouring millions into the infrastructure and quality systems necessary to move away from manual filling is unrealistic and detracts from your strengths in drug development.

Aseptic Filling Operations To Keep In-House Or Outsource Get more Bioprocess insight with our FREE newsletter sign me up Log In or Subscribe Article | September 23, 2020 Aseptic Filling Operations – To Keep In-House Or Outsource? Source: JOINN Biologics For decades, competitive innovations have been driving the sizes of devices smaller and the prices lower. This has been clearly achieved in computer tech with advances in microchips, and the same has been developing in the biotech equipment industry with both analytical test equipment and drug manufacturing equipment, making them more accessibl

related reading

• Tech vs Biotech - Celine Haliouacelinehh.com
• Multiply Labs | Robotic Biomanufacturing Infrastructuremultiplylabs.com
• The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
• Heuristics for lab robotics, and where its future may gosubstack.com
• RIF Roboticsrifrobotics.com
• Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
• The Four Pillars: A Hypothesis for Countering Catastrophic Biological Riskdefensesindepth.bio
• Neion Bioneionbio.com
• The Machine Behind Every Exceptional Sip | Overpotentialoverpotential.com
• Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
• Making Vaccine — LessWronglesswrong.com
• Astro Mechanica - Not Boring by Packy McCormicknotboring.co